Related Experiment Videos
Therapeutic frontiers in Alzheimer's disease
S W Miller1, J M Mahoney, M W Jann
1Department of Pharmacy Practice, Mercer University Southern School of Pharmacy, Atlanta, Georgia 30341.
Pharmacotherapy
|January 1, 1992
Summary
Alzheimer's disease (AD) research is ongoing, but effective treatments remain elusive. Current strategies focus on enhancing neurotransmitters and exploring novel drug delivery for cognitive impairment.
Area of Science:
- Neuroscience
- Geriatrics
- Pharmacology
Background:
- Alzheimer's disease (AD) is the most common cause of dementia in the elderly, leading to significant cognitive decline.
- The cholinergic hypothesis, suggesting loss of cholinergic neurons, remains a key area of AD research.
- Despite extensive study, the exact causes and effective treatments for Alzheimer's disease are yet to be discovered.
Framework:
- Investigating the role of cholinergic neuron loss in AD-related cognitive impairment.
- Evaluating the efficacy of current therapeutic strategies targeting acetylcholine levels.
- Exploring diverse mechanisms for new AD treatments, including cerebral protectants and nerve growth factors.
Implementation:
- Assessing drugs in development for Alzheimer's disease in the United States.
- Examining agents that enhance neuronal signal amplification and tonic stimulation.
- Developing innovative drug delivery systems to improve central nervous system (CNS) drug concentrations.
Implications:
- Highlighting the need for continued research into Alzheimer's disease etiology and treatment.
- Suggesting that novel therapeutic approaches may offer new hope for patients and families.
- Emphasizing the potential of advanced drug delivery systems in managing cognitive decline.